Decoding Pancreatic Cancer Pain: From Tumor-Nerve Crosstalk to Targeted Analgesic Strategies
International Journal of Medical Sciences · 29.07.2026 · 23 (9) · 2847-2873
DOI: 10.7150/ijms.134090 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Medical Sciences, erschienen am 29.07.2026. Verfasst von Daqiang Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Avenida Wai Long, Macau SAR, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cancer Pain, Analgesics, Pain Management. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pancreatic cancer (PC) remains one of the most lethal malignancies, with pain being a prevalent and debilitating symptom that severely impairs patients' quality of life and independently predicts poorer survival. While historically attributed to tumor mass effects, the mechanisms driving PC pain are far more complex. This review aims to synthesize the current understanding of the intricate biological underpinnings of PC-associated pain and discuss the paradigm shift towards mechanism-based therapeutic strategies. The pathogenesis of PC pain is fundamentally driven by dynamic tumor-nerve interactions. A central mechanism is perineural invasion (PNI), a pathologic hallmark wherein cancer cells infiltrate the perineural space, establishing a specialized "neural niche." Within this niche, bidirectional crosstalk involving cancer cells, Schwann cells, immune cells, and stromal components, which is mediated by neurotrophins, chemokines, and neurotransmitters, drives neural remodeling, neuroinflammation, and peripheral nociceptor sensitization. These peripheral signals subsequently induce central sensitization within the spinal cord and brain, perpetuating chronic, refractory pain. While conventional analgesics and interventions like celiac plexus neurolysis remain the mainstay, their relief is often incomplete and transient, as they fail to address these underlying biological drivers. A therapeutic paradigm shift is underway, moving from symptomatic palliation towards mechanism-based interventions. Emerging strategies, including molecularly targeted inhibitors, neuromodulation, and precision nanomedicine platforms, aim to directly disrupt the fundamental neurobiological pathways of pain. By targeting tumor-nerve crosstalk, neuroinflammation, and pathological neural plasticity, these approaches hold the potential to achieve more effective and durable analgesia, ultimately improving the lives of patients suffering from pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Avenida Wai Long, Macau SAR, China.
- Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Avenida Wai Long, Macau SAR, China.
- Department of Anesthesiology, Pain Medicine, Palliative Care, Sichuan Taikang Hospital, No.881 Xianghe 1st Street, Huayang Community, Tianfu New Area, Chengdu, Sichuan, P.R. China.
- Department of Cardiology, Zhuhai People's Hospital and 1st Affiliated Hospital of Macau University of Science and Technology, Zhuhai, China.
Zitieren
APA
Zhao, D., Hu, Q., Wang, H., Huang, Y., Li, Y., Qian, Y., Gao, L., Ding, Q., & Zhu, Y. Z. (2026). Decoding Pancreatic Cancer Pain: From Tumor-Nerve Crosstalk to Targeted Analgesic Strategies. International Journal of Medical Sciences, 23(9), 2847-2873. https://doi.org/10.7150/ijms.134090
Vancouver
Zhao D, Hu Q, Wang H, Huang Y, Li Y, Qian Y, et al. Decoding Pancreatic Cancer Pain: From Tumor-Nerve Crosstalk to Targeted Analgesic Strategies. International Journal of Medical Sciences. 2026;23(9):2847-2873. doi:10.7150/ijms.134090
BibTeX
@article{Zhao2026,
author = {Zhao, Daqiang and Hu, Qingwen and Wang, Hanxuan and Huang, Yu and Li, Yuqian and Qian, Yu and Gao, Li and Ding, Qian and Zhu, Yi Zhun},
title = {Decoding Pancreatic Cancer Pain: From Tumor-Nerve Crosstalk to Targeted Analgesic Strategies},
journal = {International Journal of Medical Sciences},
year = {2026},
volume = {23},
number = {9},
pages = {2847--2873},
doi = {10.7150/ijms.134090}
}
EUVIMED